Page last updated: 2024-09-05

organophosphonates and Osteoporotic Fractures

organophosphonates has been researched along with Osteoporotic Fractures in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lane, JM; Rebolledo, BJ; Unnanuntana, A1
Bedimo, R; Drechsler, H; Maalouf, NM; Tebas, P; Zhang, S1
Powderly, WG1

Reviews

1 review(s) available for organophosphonates and Osteoporotic Fractures

ArticleYear
Osteoporosis and bone health in HIV.
    Current HIV/AIDS reports, 2012, Volume: 9, Issue:3

    Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adenine; Alcohol Drinking; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Density; Bone Density Conservation Agents; Female; Humans; Inflammation; Male; Organophosphonates; Osteomalacia; Osteoporosis; Osteoporotic Fractures; Smoking; Tenofovir; Weight Loss

2012

Other Studies

2 other study(ies) available for organophosphonates and Osteoporotic Fractures

ArticleYear
Bilateral pathologic hip fractures associated with antiretroviral therapy: a case report.
    The Journal of bone and joint surgery. American volume, 2011, Jul-20, Volume: 93, Issue:14

    Topics: Accidental Falls; Adenine; Alendronate; Anti-HIV Agents; Bone Density Conservation Agents; Comorbidity; Fanconi Syndrome; Female; Femoral Neck Fractures; Fractures, Spontaneous; Hip Fractures; HIV Infections; Humans; Magnetic Resonance Imaging; Middle Aged; Organophosphonates; Osteoporotic Fractures; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure

2011
Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents.
    AIDS (London, England), 2012, Apr-24, Volume: 26, Issue:7

    Topics: Adenine; Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Hip Fractures; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Middle Aged; Organophosphonates; Osteoporotic Fractures; Retrospective Studies; Risk; Risk Factors; Ritonavir; Spinal Fractures; Tenofovir; Time Factors; Treatment Outcome; Wrist Injuries; Young Adult

2012